お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
974885

結核検査の世界市場 (2017-2025年):産業分析・市場動向・市場シェア・成長予測

Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

出版日: | 発行: Transparency Market Research | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.87円
結核検査の世界市場 (2017-2025年):産業分析・市場動向・市場シェア・成長予測
出版日: 2020年11月09日
発行: Transparency Market Research
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の結核検査の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、企業間の主な展開、市場規模の推移・予測、テストタイプ・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 序文

第2章 仮定・調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 市場分析・予測

第5章 重要考察

  • TB:世界の負担
  • MDR-TB:世界の負担
  • 従来型検査・診断の課題
  • M&A

第6章 市場分析・予測:テストタイプ別

  • 主要調査結果・主な展開
  • 市場の推移・予測
    • 胸部X線
    • 培養検査
    • IGRA
    • TST
    • NAT・Xpert検査
    • 血清学的検査
    • スミア顕微鏡
    • その他
  • 市場の魅力

第7章 市場分析・予測:エンドユーザー別

  • 主要調査結果・主な展開
  • 市場の推移・予測
    • 院内ラボ
    • リファレンスラボ
    • 医師のオフィスのラボ
    • 学術・研究ラボ
    • その他
  • 市場の魅力

第8章 市場分析・予測:地域別

  • 主要調査結果・主な展開
  • 市場の推移・予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力

第9章 北米市場の分析・予測:主要国別

第10章 欧州市場の分析・予測:主要国別

第11章 アジア太平洋市場の分析・予測:主要国別

第12章 ラテンアメリカ市場の分析・予測:主要国別

第13章 中東・アフリカ市場の分析・予測:主要国別

第14章 競合情勢

  • 競合マトリックス
  • 企業のシェア・位置付け
  • 競合事業戦略
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Alere, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • LIONEX Diagnostics & Therapeutics GmbH.
    • Danaher Corporation
    • Creative Diagnostics
    • QIAGEN
    • Hain Lifescience GmbH.
    • Oxford Immunotec Ltd.
    • Hologic, Inc.
    • Cepheid
    • Akonni Biosystems, Inc.
    • bioMerieux SA
    • Epistem Ltd
図表

List of Table

  • Table 01: Top 10 High TB burden countries with estimated number of new TB cases globally
  • Table 02: Estimated number of MDR-TB among all notified TB cases in high burden countries (2018)
  • Table 03: TB R&D Funders by Rank in 2018
  • Table 04: Tuberculosis Diagnostics tests Pipeline
  • Table 05: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 06: Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 07: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2017-2027
  • Table 08: North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 09: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2017-2027
  • Table 10: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017-2027
  • Table 11: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 12: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 13: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2017-2027
  • Table 14: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 15: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 16: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017-2027
  • Table 17: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 18: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 19: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017-2027
  • Table 20: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 21: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 22: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2017-2027

List of Figure

  • Figure 01: Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2018-2027
  • Figure 02: Market Value Share, by Test Type (2018)
  • Figure 03: Market Value Share, by End User (2018)
  • Figure 04: Market Value Share, by Region (2018)
  • Figure 05: Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis
  • Figure 06: Total TB R&D Funding, 2005-2015
  • Figure 07: Total TB R&D Funding by Funder Category, 2015
  • Figure 08: Total TB R&D Funding by Funder Category, 2005-2015 (Mn)
  • Figure 09: Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 10: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2017-2027
  • Figure 11: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,
  • Figure 12: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2017-2027
  • Figure 13: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux test (TST), 2017-2027
  • Figure 14: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2017-2027
  • Figure 15: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,
  • Figure 16: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2017-2027
  • Figure 17: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2017-2027
  • Figure 18: Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025
  • Figure 19: Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 20: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027
  • Figure 21: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2017-2027
  • Figure 22: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician's Office Laboratories, 2017-2027
  • Figure 23: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2017-2027
  • Figure 24: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 25: Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025
  • Figure 26: Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2017-2027
  • Figure 27: Global Tuberculosis Testing Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 28: Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025
  • Figure 29: North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 30: North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 31: North America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 32: North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 33: North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 34: North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
  • Figure 35: North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
  • Figure 36: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2017-2027
  • Figure 37: Europe Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 38: Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 39: Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 40: Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 41: Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
  • Figure 42: Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
  • Figure 43: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 44: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 45: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 46: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 47: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 48: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
  • Figure 49: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
  • Figure 50: Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 51: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 52: Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 53: Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 54: Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 55: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
  • Figure 56: Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
  • Figure 57: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 58: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 59: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 60: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 61: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2018 and 2027
  • Figure 62: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2018-2027
  • Figure 63: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2018-2027
  • Figure 64: Thermo Fisher Scientific, Inc.- Breakdown of Net Sales (% Share), by Business segments (2018)
  • Figure 65: Thermo Fisher Scientific, Inc.- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 66: Alere, Inc.- Revenue Split, by Operating Segment, 2015
  • Figure 67: Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2018
  • Figure 68: Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2018
  • Figure 69: Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 70: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015
  • Figure 71: F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2015-2018
  • Figure 72: Danaher Corporation - Breakdown of Revenue, by Region, 2018
  • Figure 73: Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012-2018
  • Figure 74: QIAGEN- Breakdown of Net Sales, by Business Segment, 2018
  • Figure 75: QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2015-2018
  • Figure 76: Oxford Immunotec Ltd.- Breakdown of Net Sales, by region, 2015
  • Figure 77: Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 78: Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 79: Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 80: Cepheid - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 81: Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 82: bioMerieux SA - Breakdown of Net Sales, by Country/Region, 2018
  • Figure 83: bioMerieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
  • Figure 84: Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015
  • Figure 85: Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2018
目次
Product Code: TMRGL2267

Title:
Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test (TST), Nucleic Acid Testing (NAT), Xpert Test, Serological Tests, and Smear Microscopy; End-User - Academics and Research, Hospitals Laboratories, Physician's Office Laboratories, and Reference Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025.

Global Tuberculosis Testing Market - Scope of Report

TMR's report on the global Tuberculosis Testing Market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global Tuberculosis Testing Market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Tuberculosis Testing Market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global tuberculosis testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global tuberculosis testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global tuberculosis testing market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global tuberculosis testing market.

The report delves into the competitive landscape of the global tuberculosis testing market. Key players operating in the global Tuberculosis Testing Market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Tuberculosis Testing Market that have been profiled in this report.

Key Questions Answered in Global Tuberculosis Testing Market Report

What is the scope of growth of product companies in the global tuberculosis testing market?

What will be the Y-o-Y growth of the global Tuberculosis Testing Market between 2019 and 2027?

What is the influence of changing trends in technologies on the global tuberculosis testing market?

Will North America continue to be the most profitable market for global tuberculosis testing providers?

Which factors are anticipated to hamper the growth of the global Tuberculosis Testing Market during the forecast period?

Which are the leading companies in the global tuberculosis testing market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global Tuberculosis Testing Market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Tuberculosis Testing Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the Tuberculosis Testing Market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Tuberculosis Testing Market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Tuberculosis Testing Market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global Tuberculosis Testing Market more reliably and accurately.

Regional Segmentation of Tuberculosis Testing Market

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global tuberculosis testing market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Test Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Tuberculosis Testing Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Burden of TB Worldwide
  • 5.2. Burden of MDR-TB Worldwide
  • 5.3. Challenges of Traditional Testing/Diagnostic Methods
  • 5.4. Mergers & Acquisitions

6. Global Tuberculosis Testing Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Tuberculosis Testing Market Value Forecast, by Test Type, 2017-2027
    • 6.2.1. Chest X-Ray
    • 6.2.2. Culture Based Tests
    • 6.2.3. Interferon-Gamma Release Assays (IGRA)
    • 6.2.4. Mantoux Test (TST)
    • 6.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 6.2.6. Serological Tests
    • 6.2.7. Smear Microscopy
    • 6.2.8. Other Tests (ADA, etc.)
  • 6.3. Global Tuberculosis Testing Market Attractiveness, by Test Type

7. Global Tuberculosis Testing Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Tuberculosis Testing Market Value Forecast, by End-user, 2017-2027
    • 7.2.1. Hospitals Laboratories
    • 7.2.2. Reference Laboratories
    • 7.2.3. Physician's Office Laboratories
    • 7.2.4. Academics and Research
    • 7.2.5. Others (Home Health Agencies, etc.)
  • 7.3. Global Tuberculosis Testing Market Attractiveness, by End-user

8. Global Tuberculosis Testing Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Tuberculosis Testing Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. North America Tuberculosis Testing Market Attractiveness, by Region

9. North America Tuberculosis Testing Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 9.2.1. Chest X-Ray
    • 9.2.2. Culture Based Tests
    • 9.2.3. Interferon-Gamma Release Assays (IGRA)
    • 9.2.4. Mantoux Test (TST)
    • 9.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 9.2.6. Serological Tests
    • 9.2.7. Smear Microscopy
    • 9.2.8. Other Tests (ADA, etc.)
  • 9.3. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 9.3.1. Hospitals Laboratories
    • 9.3.2. Reference Laboratories
    • 9.3.3. Physician's Office Laboratories
    • 9.3.4. Academics and Research
    • 9.3.5. Others (Home Health Agencies, etc.)
  • 9.4. North America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country, 2017-2027
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Tuberculosis Testing Market Attractiveness Analysis
    • 9.5.1. By Test Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Tuberculosis Testing Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 10.2.1. Chest X-Ray
    • 10.2.2. Culture Based Tests
    • 10.2.3. Interferon-Gamma Release Assays (IGRA)
    • 10.2.4. Mantoux Test (TST)
    • 10.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 10.2.6. Serological Tests
    • 10.2.7. Smear Microscopy
    • 10.2.8. Other Tests (ADA, etc.)
  • 10.3. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 10.3.1. Hospitals Laboratories
    • 10.3.2. Reference Laboratories
    • 10.3.3. Physician's Office Laboratories
    • 10.3.4. Academics and Research
    • 10.3.5. Others (Home Health Agencies, etc.)
  • 10.4. Europe Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Tuberculosis Testing Market Attractiveness Analysis
    • 10.5.1. By Test Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Tuberculosis Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 11.2.1. Chest X-Ray
    • 11.2.2. Culture Based Tests
    • 11.2.3. Interferon-Gamma Release Assays (IGRA)
    • 11.2.4. Mantoux Test (TST)
    • 11.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 11.2.6. Serological Tests
    • 11.2.7. Smear Microscopy
    • 11.2.8. Other Tests (ADA, etc.)
  • 11.3. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 11.3.1. Hospitals Laboratories
    • 11.3.2. Reference Laboratories
    • 11.3.3. Physician's Office Laboratories
    • 11.3.4. Academics and Research
    • 11.3.5. Others (Home Health Agencies, etc.)
  • 11.4. Asia Pacific Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis
    • 11.5.1. By Test Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Tuberculosis Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 12.2.1. Chest X-Ray
    • 12.2.2. Culture Based Tests
    • 12.2.3. Interferon-Gamma Release Assays (IGRA)
    • 12.2.4. Mantoux Test (TST)
    • 12.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 12.2.6. Serological Tests
    • 12.2.7. Smear Microscopy
    • 12.2.8. Other Tests (ADA, etc.)
  • 12.3. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 12.3.1. Hospitals Laboratories
    • 12.3.2. Reference Laboratories
    • 12.3.3. Physician's Office Laboratories
    • 12.3.4. Academics and Research
    • 12.3.5. Others (Home Health Agencies, etc.)
  • 12.4. Latin America Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America Latin America
  • 12.5. Latin America Tuberculosis Testing Market Attractiveness Analysis
    • 12.5.1. By Test Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Tuberculosis Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
    • 13.2.1. Chest X-Ray
    • 13.2.2. Culture Based Tests
    • 13.2.3. Interferon-Gamma Release Assays (IGRA)
    • 13.2.4. Mantoux Test (TST)
    • 13.2.5. Nucleic Acid Testing (NAT), Xpert test
    • 13.2.6. Serological Tests
    • 13.2.7. Smear Microscopy
    • 13.2.8. Other Tests (ADA, etc.)
  • 13.3. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2027
    • 13.3.1. Hospitals Laboratories
    • 13.3.2. Reference Laboratories
    • 13.3.3. Physician's Office Laboratories
    • 13.3.4. Academics and Research
    • 13.3.5. Others (Home Health Agencies, etc.)
  • 13.4. Middle East & Africa Tuberculosis Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Tuberculosis Testing Market Attractiveness Analysis
    • 13.5.1. By Test Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 14.2. Market Share / Position Analysis, by Company, 2018
  • 14.3. Competitive Business Strategies
  • 14.4. Company Profiles
    • 14.4.1. Thermo Fisher Scientific, Inc.
      • 14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.1.2. Growth Strategies
      • 14.4.1.3. SWOT Analysis
    • 14.4.2. Alere, Inc.
      • 14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.2.2. Growth Strategies
      • 14.4.2.3. SWOT Analysis
    • 14.4.3. Becton, Dickinson and Company
      • 14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.3.2. Growth Strategies
      • 14.4.3.3. SWOT Analysis
    • 14.4.4. F. Hoffmann-La Roche AG
      • 14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.4.2. Growth Strategies
      • 14.4.4.3. SWOT Analysis
    • 14.4.5. LIONEX Diagnostics & Therapeutics GmbH.
      • 14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.5.2. Growth Strategies
      • 14.4.5.3. SWOT Analysis
    • 14.4.6. Danaher Corporation
      • 14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.6.2. Growth Strategies
      • 14.4.6.3. SWOT Analysis
    • 14.4.7. Creative Diagnostics
      • 14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.7.2. Growth Strategies
      • 14.4.7.3. SWOT Analysis
    • 14.4.8. QIAGEN
      • 14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.8.2. Growth Strategies
      • 14.4.8.3. SWOT Analysis
    • 14.4.9. Hain Lifescience GmbH.
      • 14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.9.2. Growth Strategies
      • 14.4.9.3. SWOT Analysis
    • 14.4.10. Oxford Immunotec Ltd.
      • 14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.10.2. Growth Strategies
      • 14.4.10.3. SWOT Analysis
    • 14.4.11. Hologic, Inc.
      • 14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.11.2. Growth Strategies
      • 14.4.11.3. SWOT Analysis
    • 14.4.12. Cepheid
      • 14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.12.2. Growth Strategies
      • 14.4.12.3. SWOT Analysis
    • 14.4.13. Akonni Biosystems, Inc.
      • 14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.13.2. Growth Strategies
      • 14.4.13.3. SWOT Analysis
    • 14.4.14. bioMerieux SA
      • 14.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.14.2. Growth Strategies
      • 14.4.14.3. SWOT Analysis
    • 14.4.15. Epistem Ltd
      • 14.4.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.15.2. Growth Strategies
      • 14.4.15.3. SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.